Correction: Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection

Documenti analoghi

• Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection
  di: Duwal, Sulav, et al.
  Pubblicazione: (2012)
• Optimal Treatment Strategies in the Context of ‘Treatment for Prevention’ against HIV-1 in Resource-Poor Settings
  di: Duwal, Sulav, et al.
  Pubblicazione: (2015)
• Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes
  di: Duwal, Sulav, et al.
  Pubblicazione: (2018)
• In Vitro HIV-1 Evolution in Response to Triple Reverse Transcriptase Inhibitors & In Silico Phenotypic Analysis
  di: Rath, Barbara A., et al.
  Pubblicazione: (2013)
• Multiscale Systems‐Pharmacology Pipeline to Assess the Prophylactic Efficacy of NRTIs Against HIV‐1
  di: Duwal, S, et al.
  Pubblicazione: (2016)